Clinical Trial Update: National GMA Post-market Clinical Follow-up Study (GRACE)

View source ↗

Summary

Post-market clinical follow-up study (GRACE) sponsored by Adacyte Therapeutics SL, currently recruiting participants for Crohn's disease and ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Adacyte Therapeutics SL Investigational Product

Snippet

Sponsor: Adacyte Therapeutics SL | Conditions: Crohn Disease, Ulcerative Colitis | Status: RECRUITING